{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:18:11Z","timestamp":1772749091729,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jjcc.2013.03.008","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T04:45:27Z","timestamp":1368247527000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: The COMPACT-CAD study"],"prefix":"10.1016","volume":"62","author":[{"given":"Kazumasa","family":"Kurogi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Tayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Biwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2013.03.008_bib0005","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0010","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jjcc.2011.07.002","article-title":"Recurrence of angina pectoris after percutaneous coronary intervention is reduced by statins in Japanese patients","volume":"58","author":"Tsunoda","year":"2011","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0020","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0025","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0021-9150(99)00146-X","article-title":"Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs","volume":"146","author":"Suzuki","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0035","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1517\/13543784.9.11.2653","article-title":"NK-104: a novel synthetic HMG-CoA reductase inhibitor","volume":"9","author":"Kajinami","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0040","first-page":"251","article-title":"Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison","volume":"52","author":"Saito","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0045","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00125-006-0269-5","article-title":"Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control","volume":"49","author":"Nakata","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","volume":"54","author":"Hiro","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jjcc.2012.04.003","article-title":"Effect of pitavastatin treatment on changes of plaque volume and composition according to the reduction of high-sensitivity C-reactive protein levels","volume":"60","author":"Hong","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0060","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.clinthera.2008.05.017","volume":"30","author":"Sasaki","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0065","doi-asserted-by":"crossref","first-page":"19L","DOI":"10.1016\/S0002-9149(00)01464-8","article-title":"High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial","volume":"86","author":"Boden","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0070","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","article-title":"Macrophage reverse cholesterol transport: key to the regression of atherosclerosis","volume":"113","author":"Cuchel","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0075","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/HCO.0b013e3283043806","article-title":"Multiple actions of high-density lipoprotein","volume":"23","author":"Florentin","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0080","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jacc.2010.01.008","article-title":"High-density lipoprotein and coronary heart disease: current and future therapies","volume":"55","author":"Natarajan","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0085","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1194\/jlr.P002816","article-title":"Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database","volume":"51","author":"Barter","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0090","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1067\/mhj.2002.128049","article-title":"Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia","volume":"144","author":"Olsson","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1586\/erc.11.47","article-title":"Efficacy and safety of pitavastatin in Japanese patients with hypercholesterolemia: LIVES study and subanalysis","volume":"9","author":"Yokote","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0100","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5551\/jat.5405","article-title":"Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions","volume":"17","author":"Yamashita","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2011.04.043","article-title":"Regulation mechanism of ABCA1 expression by statins in hepatocytes","volume":"662","author":"Kobayashi","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0120","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/01.RES.0000268411.49545.9c","article-title":"Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1\/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages","volume":"100","author":"Yano","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/ATVBAHA.107.160663","article-title":"Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3\/IFN-beta pathway in macrophages","volume":"28","author":"Abe","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2010.04.019","article-title":"Beneficial direct adipotropic actions of pitavastatin in vitro and their manifestations in obese mice","volume":"212","author":"Ishihara","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2013.03.008_bib0135","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1253\/circj.66.1087","article-title":"Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia","volume":"66","author":"Matsuzaki","year":"2002","journal-title":"Circ J"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508713001184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508713001184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:51:22Z","timestamp":1760273482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508713001184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0914508713001184"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2013.03.008","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: The COMPACT-CAD study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2013.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}